Spots Global Cancer Trial Database for ascites
Every month we try and update this database with for ascites cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid | NCT02891642 | Malignancy Pleural Effusio... Pleural Disease... Ascites | Immunomagnetic ... | 18 Years - 80 Years | The First Affiliated Hospital with Nanjing Medical University | |
| T Helper Cytokines in End Stage Colorectal Cancers | NCT04540146 | Colorectal Canc... | Flow-Cytometric... | 18 Years - 80 Years | Istanbul Training and Research Hospital | |
| 13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients. | NCT05025878 | Ovarian Cancer Ascites | [U-13C]Glucose | 18 Years - | British Columbia Cancer Agency | |
| Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid | NCT02891642 | Malignancy Pleural Effusio... Pleural Disease... Ascites | Immunomagnetic ... | 18 Years - 80 Years | The First Affiliated Hospital with Nanjing Medical University | |
| The Role of Intravenous Albumin Replacement During Abdominal Paracentesis in Patients With Malignancy Related Ascites | NCT02811406 | Ascites Hypotension | Receives IV alb... Do not receive ... | 21 Years - 99 Years | National University Hospital, Singapore | |
| Symptomatic Ascites Drainage With a Patient-controlled Vascular Catheter. | NCT02724683 | Malignant Ascit... | Ascites drainag... Interview. Quality of life... Quality of proc... Nutritional sta... | 18 Years - | Gdynia Oncology Center | |
| International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) | NCT03210298 | Peritoneum Canc... Peritoneum Neop... Pleural Cancer Pleural Effusio... Pleural Mesothe... Ovarian Cancer Gastric Cancer Appendix Cancer Pseudomyxoma Pe... Colorectal Canc... Pancreas Cancer Gallbladder Can... Ascites CUP Chemotherapeuti... | PIPAC | 10 Years - | University of Magdeburg | |
| International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) | NCT03210298 | Peritoneum Canc... Peritoneum Neop... Pleural Cancer Pleural Effusio... Pleural Mesothe... Ovarian Cancer Gastric Cancer Appendix Cancer Pseudomyxoma Pe... Colorectal Canc... Pancreas Cancer Gallbladder Can... Ascites CUP Chemotherapeuti... | PIPAC | 10 Years - | University of Magdeburg | |
| The Role of Intravenous Albumin Replacement During Abdominal Paracentesis in Patients With Malignancy Related Ascites | NCT02811406 | Ascites Hypotension | Receives IV alb... Do not receive ... | 21 Years - 99 Years | National University Hospital, Singapore | |
| PMCF Study of the CE-marked Drainova® ArgentiC Catheter | NCT06436807 | Pleural Effusio... Pleural Effusio... Ascites Ascites, Malign... | Indwelling cath... | 18 Years - | ewimed GmbH | |
| AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites | NCT02417753 | Ovarian Cancer Ovarian Neoplas... Ascites Gastrointestina... Gastrointestina... | AZD9150 | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites | NCT00327444 | Ovarian Neoplas... Ascites | aflibercept (zi... Placebo aflibercept (zi... | 18 Years - | Sanofi | |
| T Helper Cytokines in End Stage Colorectal Cancers | NCT04540146 | Colorectal Canc... | Flow-Cytometric... | 18 Years - 80 Years | Istanbul Training and Research Hospital | |
| Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT | NCT02638051 | Peritoneal Neop... Ascites Yang Deficiency Yin Deficiency | Modulated Elect... TCM Herbal Deco... IPCI (CDDP+5FU) | 18 Years - 75 Years | Galenic Research Institute Ltd | |
| Immune Checkpoints in Intraabdominal Ascites Fluid | NCT04540159 | Colorectal Canc... | Flow-cytometric... | 18 Years - 80 Years | Istanbul Training and Research Hospital | |
| Treatment With Octreotide in Patients With Lymphangioleiomyomatosis | NCT00005906 | Lymphangioleiom... Lymphangiomyoma... Pleural Effusio... Ascites | Octreotide | 18 Years - 65 Years | National Institutes of Health Clinical Center (CC) | |
| Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer | NCT02742428 | Ascites Ovarian Epithel... Malnutrition | Systematic asci... Acute paracente... Interview. Quality of life... Nutritional sta... | 18 Years - | Gdynia Oncology Center | |
| B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites | NCT01150916 | Heart Failure Liver Cirrhosis Ascites Carcinomatosis | BNP, SAAG, asci... | 18 Years - | University of Sao Paulo | |
| Safety and Effectiveness Study of Tumor Cell-derived Microparticles to Treat Malignant Ascites and Pleural Effusion | NCT01854866 | Malignant Pleur... Malignant Ascit... | Drug-packaging ... | 18 Years - 70 Years | Huazhong University of Science and Technology | |
| B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites | NCT01150916 | Heart Failure Liver Cirrhosis Ascites Carcinomatosis | BNP, SAAG, asci... | 18 Years - | University of Sao Paulo | |
| Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites | NCT00326885 | Malignant Ascit... | catumaxomab | 18 Years - | Neovii Biotech | |
| Treatment With Octreotide in Patients With Lymphangioleiomyomatosis | NCT00005906 | Lymphangioleiom... Lymphangiomyoma... Pleural Effusio... Ascites | Octreotide | 18 Years - 65 Years | National Institutes of Health Clinical Center (CC) | |
| Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites | NCT00327444 | Ovarian Neoplas... Ascites | aflibercept (zi... Placebo aflibercept (zi... | 18 Years - | Sanofi | |
| BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal | NCT03367247 | Gynecologic Can... Gastrointestina... | BOLSTER Enhanced Discha... | 18 Years - | Dana-Farber Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
